185 related articles for article (PubMed ID: 2426020)
1. Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin.
Barnass S; Mace J; Steele J; Torres P; Gervasoni B; Ravioli R; Terencio J; Rook GA; Waters MF
Clin Exp Immunol; 1986 Apr; 64(1):41-9. PubMed ID: 2426020
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
3. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
[TBL] [Abstract][Full Text] [Related]
4. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
5. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
7. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
Brett SJ; Kingston AE; Colston MJ
Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217
[TBL] [Abstract][Full Text] [Related]
8. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
[TBL] [Abstract][Full Text] [Related]
9. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the immune deficit in leprosy patients and the effect of recombinant IL-2 in vitro.
Locniskar M; McEniry DW; Mudd DW; Rose P; Lucas DC; Larrick J; McAdam KP
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):249-60. PubMed ID: 3298472
[TBL] [Abstract][Full Text] [Related]
11. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
12. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
Chattree V; Khanna N; Rao DN
Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.
Kaleab B; Ottenoff T; Converse P; Halapi E; Tadesse G; Rottenberg M; Kiessling R
Eur J Immunol; 1990 Dec; 20(12):2651-9. PubMed ID: 2269329
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA
J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496
[TBL] [Abstract][Full Text] [Related]
15. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
16. The immunobiology of leprosy.
Kaplan G; Cohn ZA
Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
[TBL] [Abstract][Full Text] [Related]
17. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.
Misra N; Murtaza A; Walker B; Narayan NP; Misra RS; Ramesh V; Singh S; Colston MJ; Nath I
Immunology; 1995 Sep; 86(1):97-103. PubMed ID: 7590888
[TBL] [Abstract][Full Text] [Related]
18. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
19. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
[TBL] [Abstract][Full Text] [Related]
20. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease.
de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH
J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]